HHS is escalating its war with medical organizations including the American Academy of Pediatrics and the American Psychiatric Association, touting the results of a study the department commissioned ...

The Trump administration's revamp of the 1115 waiver budget neutrality process will likely affect the 15 states with demonstrations set to expire in 2026, according to a Manatt analysis released this ...

Companies developing agentic AI models for use in health care are pushing for a system of national licensure to avoid participation in the Interstate Medical Licensing Compact (IMLC), and at least one ...

The Trump administration’s most favored nation policy impacts about 89% of the brand drug market now that nine mid-sized manufacturers have signed up to offer their products to Medicaid at prices ...

The health insurance industry is highlighting a new Health Affairs analysis that finds the No Surprises Act’s independent dispute resolution process resulted in $22.4 billion in costs from 2022 to ...

Federal employees have filed a class-action lawsuit against the federal Office of Personnel Management (OPM) challenging the Trump administration’s exclusion of gender-affirming care coverage from ...

A key lawsuit between FDA and the states of Florida and Texas, which are attempting to compel FDA to revoke its 2000 approval of mifepristone, which would eliminate access to medication abortion ...

Democrats on the Senate Finance Committee are interested in establishing a subscription model to boost access to medicines like GLP-1s, one of many affordability policies lawmakers are considering ...

Arizona is fairly confident certain parts of its broad 1115 waiver, including its Medicaid managed care delivery system and home- and community-based services, will survive the administration's new ...

HHS Secretary Robert F. Kennedy Jr. is escalating what’s increasingly becoming widespread scrutiny of the American Medical Association’s (AMA) control over the nation’s medical billing codes, accusing ...

The American Hospital Association is denouncing draft legislation it says would shift power within the 340B program to drug manufacturers, which would no longer be required to provide upfront ...

Only one case attempting to block further implementation of Medicare drug price negotiation remains without a district or appeals court ruling after the U.S. Court of Appeals for the Fifth Circuit ...